Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer

AS Nascimento; LL Peres; AVS Fari; R Milani; Rodrigo Da Silva; CD Fernandes; Maikel Peppelenbosch; CV Ferreira-Halder; WF Zambuzzi

doi:10.18632/oncotarget.21801

Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer

AS Nascimento, LL Peres, AVS Fari, R Milani, Rodrigo Da Silva, CD Fernandes, Maikel Peppelenbosch, CV Ferreira-Halder, WF Zambuzzi

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

16 Citations (Scopus)

9 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	114756-114768
Number of pages	13
Journal	Oncotarget
Volume	8
Issue number	70
DOIs	https://doi.org/10.18632/oncotarget.21801
Publication status	Published - 2017

Research programs

EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.18632/oncotarget.21801

REPUB_103814.pdfFinal published version, 3.91 MB

http://hdl.handle.net/1765/103814

Cite this

@article{315c34e8f76b470096a37a3b5dcb4501,

title = "Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer",

author = "AS Nascimento and LL Peres and AVS Fari and R Milani and {Da Silva}, Rodrigo and CD Fernandes and Maikel Peppelenbosch and CV Ferreira-Halder and WF Zambuzzi",

year = "2017",

doi = "10.18632/oncotarget.21801",

language = "Undefined/Unknown",

volume = "8",

pages = "114756--114768",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "70",

}

TY - JOUR

T1 - Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer

AU - Nascimento, AS

AU - Peres, LL

AU - Fari, AVS

AU - Milani, R

AU - Da Silva, Rodrigo

AU - Fernandes, CD

AU - Peppelenbosch, Maikel

AU - Ferreira-Halder, CV

AU - Zambuzzi, WF

PY - 2017

Y1 - 2017

U2 - 10.18632/oncotarget.21801

DO - 10.18632/oncotarget.21801

M3 - Article

C2 - 29383118

SN - 1949-2553

VL - 8

SP - 114756

EP - 114768

JO - Oncotarget

JF - Oncotarget

IS - 70

ER -